This is an old revision of this page, as edited by Ozzie10aaaa (talk | contribs) at 20:01, 9 January 2023 (Cleaned up using AutoEd). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 20:01, 9 January 2023 by Ozzie10aaaa (talk | contribs) (Cleaned up using AutoEd)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff) Chemical compound Pharmaceutical compoundClinical data | |
---|---|
ATC code |
|
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.001.131 |
Chemical and physical data | |
Formula | C14H14N2O4S |
Molar mass | 306.34 g·mol |
3D model (JSmol) | |
SMILES
| |
InChI
| |
(verify) |
Acediasulfone (INN) is an antimicrobial drug, which also has antimalarial activity. It is a long-acting prodrug of dapsone, which is used for treating leprosy.
Synthesis
Dapsone is somewhat inconvenient to administer to patients because of its rather low water solubility.
In the search for more easily administered drugs, dapsone (1) was reacted with bromoacetic acid to give acediasulfone (2) which can be administered as a water-soluble salt.
References
- Jackson EL (February 1948). "Certain N-alkyl, N-carboxyalkyl and N-hydroxyalkyl derivatives of 4,4'-diaminodiphenyl sulfone". Journal of the American Chemical Society. 70 (2): 680–4. doi:10.1021/ja01182a074. PMID 18907772.
This antiinfective drug article is a stub. You can help Misplaced Pages by expanding it. |